232
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma

, , ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 49-55 | Received 28 Sep 2022, Accepted 06 Jan 2023, Published online: 22 Jan 2023

References

  • Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–1748. doi:10.1038/s41375-022-01620-2
  • Kanaya M, Endo T, Hashimoto D, et al. Diffuse large B-cell lymphoma with a bulky mass in the cranial vault. Int J Hematol. 2017;106(2):147–148. doi:10.1007/s12185-017-2229-x
  • da Rocha AJ, da Rocha TM, da Silva CJ, Paes RP, Bruniera P, Chiattone CS. Cranial vault lymphoma: a systematic review of five patients. J Neurooncol. 2010;100(1):9–15. doi:10.1007/s11060-010-0137-5
  • Kosugi S, Kume M, Sato J, et al. Diffuse large B-cell lymphoma with mass lesions of skull vault and ileocecum. J Clin Exp Hematop. 2013;53(3):215–219. doi:10.3960/jslrt.53.215
  • Umemura T, Nakano Y, Soejima Y, et al. Characteristics of bone destruction in cranial vault lymphoma compared with other skull tumors. J UOEH. 2019;41(3):335–342. doi:10.7888/juoeh.41.335
  • Jaiswal M, Gandhi A, Purohit D, Singhvi S, Mittal RS. Primary non-Hodgkin’s lymphoma of the skull with extra and intracranial extension presenting with bulky scalp mass lesion. Asian J Neurosurg. 2016;11(4):444. doi:10.4103/1793-5482.145093
  • Lee SH, Yun SJ. Early-stage primary cranial vault lymphoma in a 50-year-old man: presenting as only sclerosis and mimicking osteoma. Ann Hematol. 2018;97(1):183–184. doi:10.1007/s00277-017-3121-8
  • Mongia S, Shukla D, Devi BI, Reddy TV. Primary cranial vault non-Hodgkin’s lymphoma. Neurol India. 2003;51(2):293–294.
  • Toyota E, Taslimi S, Alkins R. Optimal management of calvarial lymphoma: a meta-analysis. World Neurosurg. 2021;151:e484–e494. doi:10.1016/j.wneu.2021.04.066
  • El Asri AC, Akhaddar A, Baallal H, et al. Primary lymphoma of the cranial vault: case report and a systematic review of the literature. Acta Neurochir. 2012;154(2):257–265. doi:10.1007/s00701-011-1124-0
  • Dobran M, Paracino R, Mancini F, Nasi D. Primary dural lymphoma: clinical cases and literature review. Case Rep Med. 2020;21(2):2812487.
  • Chan DYC, Chan DTM, Poon WS, Wong GKC. Primary cranial vault lymphoma. Br J Neurosurg. 2018;32(2):214–215. doi:10.1080/02688697.2016.1226262
  • Ciarpaglini R, Otten P. Primary cranial vault lymphoma with brain infiltration: case report and review of the literature. Br J Neurosurg. 2012;26(5):756–758. doi:10.3109/02688697.2012.665515
  • Uchida T, Amagasaki K, Hosono A, et al. Primary diffuse large B-cell lymphoma of the cranial vault with Trousseau syndrome: a case report. J Med Case Reports. 2021;15:431. doi:10.1186/s13256-021-02979-z
  • Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI. Natural history of CNS relapse in patients with aggressive non-Hodgkin’s lymphoma: a 20-year follow-up analysis of SWOG 8516 – the Southwest Oncology Group. J Clin Oncol. 2009;27(1):114–119. doi:10.1200/JCO.2008.16.8021
  • Tai WM, Chung J, Tang PL, et al. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab. Ann Hematol. 2011;90(7):809–818. doi:10.1007/s00277-010-1150-7
  • Chapuy B, Stewart C, Andrew J, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24:679–690. doi:10.1038/s41591-018-0016-8
  • Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood. 2009;114:2467–2475. doi:10.1182/blood-2008-12-194852
  • Platta CD, Zamana F, Jacqueline G, et al. A novel truncating mutation in MYD88 in a patient with BCG adenitis, neutropenia and delayed umbilical cord separation. Clin Immunol. 2019;207:40–42. doi:10.1016/j.clim.2019.07.004
  • Bjoern Chapuy MG, Roemer M, Stewart C, et al. Targetable genetic features of primary testicular and primary central nervous system. lymphomas. Blood. 2016;127(7):869–881. doi:10.1182/blood-2015-10-673236
  • Yoshida K, Kagami H, Shimazaki K, et al. Malignant lymphoma of the cranial vault: analysis of three cases. Neuropathology. 1999;19:283–287. doi:10.1046/j.1440-1789.1999.00246.x
  • Naama O, Gazzaz M, Boucetta B, Elmoustarchid B. Elmoustarchid. Primary non-Hodgkin lymphoma of the cranial vault. Rev Neurol. 2017;173(10):668–670. doi:10.1016/j.neurol.2017.05.011
  • Senapati SB, Mishra SS, Dhir MK, Das S, Burma S. Primary skull lymphoma: a case report and review of similar cases. South Asian J Cancer. 2013;2(4):287. PMID: 24455662; PMCID: PMC3889065. doi:10.4103/2278-330X.119908
  • de Leval L, Alizadeh A, Bergsagel P, et al. Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022;140(21):2193–2227. doi:10.1182/blood.2022015854
  • Sehn L, Salles G. Diffuse large B cell lymphoma. N Engl J Med. 2021;384(9):842–858. doi:10.1056/NEJMra2027612
  • Weber T, Schmitz R. Molecular subgroups of diffuse large B cell lymphoma: biology and implications for clinical practice. Curr Oncol Rep. 2022;24:13–21. doi:10.1007/s11912-021-01155-2
  • Stelzer G, Rosen R, Plaschkes I, et al. The genecards suite: from gene data mining to disease genome sequence analysis. Curr Protoc Bioinformatics. 2016;54(1):1–30. doi:10.1002/cpbi.5
  • Safran M, Rosen N, Twik M, et al. The genecards suite chapter. In: Practical Guide to Life Science Databases. Springer; 2022:27–56.